Refining Ethical Guidelines for Early Clinical Trials of Pluripotent Stem-Cell-Derived Therapeutics for Parkinson's Disease
American Journal of Bioethics Neuroscience 6 (1):65-66 (2015)
Abstract
This article has no associated abstract. (fix it)DOI
10.1080/21507740.2014.995317
My notes
Similar books and articles
Uncertain translation, uncertain benefit and uncertain risk: Ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.Ronald K. F. Fung & Ian H. Kerridge - 2013 - Bioethics 27 (2):89-96.
Differentiation of pluripotent stem cells into retinal pigmented epithelium.R. H. Croze & D. O. Clegg - unknown
Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease.Bernard Lo & Lindsay Parham - 2010 - Journal of Law, Medicine and Ethics 38 (2):257-266.
Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease.Bernard Lo & Lindsay Parham - 2010 - Journal of Law, Medicine and Ethics 38 (2):257-266.
Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease.Z. Master, M. McLeod & I. Mendez - 2007 - Journal of Medical Ethics 33 (3):169-173.
Translating Stem Cell Research: Challenges at the Research Frontier.David Magnus - 2010 - Journal of Law, Medicine and Ethics 38 (2):267-276.
Ethical Criteria for Human Trials of Stem-Cell-Derived Dopaminergic Neurons in Parkinson's Disease.Samia A. Hurst, Alex Mauron, Shahan Momjian & Pierre R. Burkhard - 2015 - American Journal of Bioethics Neuroscience 6 (1):52-60.
Towards guidelines for informed consent for prospective stem cell research.J. Greenberg, D. C. Smith, R. J. Burman, R. Ballo & S. H. Kidson - 2015 - South African Journal of Bioethics and Law 8 (2):46.
Some Ethical Concerns About Human Induced Pluripotent Stem Cells.Yue Zheng - 2016 - Science and Engineering Ethics 22 (5):1277-1284.
Allowing Innovative Stem Cell-Based Therapies Outside of Clinical Trials: Ethical and Policy Challenges.Insoo Hyun - 2010 - Journal of Law, Medicine and Ethics 38 (2):277-285.
Evaluating the First-in-Human Clinical Trial of a Human Embryonic Stem Cell-Based Therapy.Audrey R. Chapman & Courtney C. Scala - 2012 - Kennedy Institute of Ethics Journal 22 (3):243-261.
Stem Cells Therapy and Research. Benefits and Ethical Challences.Nicolae Ovidiu Grad, Ionel Ciprian Pop & Ion Aurel Mironiuc - 2012 - Journal for the Study of Religions and Ideologies 11 (32):190-205.
Moral complicity in induced pluripotent stem cell research.Mark T. Brown - 2009 - Kennedy Institute of Ethics Journal 19 (1):pp. 1-22.
Which patient groups should be asked to participate in first-in-human trials of stem-cell-based therapies?Kristina Hug & Göran Hermerén - 2012 - Journal of Clinical Ethics 23 (3):256-271.
Bringing prosocial values to translational, disease-specific stem cell research.Reuben Sass - 2014 - BMC Medical Ethics 15 (1):16.
Analytics
Added to PP
2018-06-22
Downloads
5 (#1,170,814)
6 months
1 (#454,876)
2018-06-22
Downloads
5 (#1,170,814)
6 months
1 (#454,876)
Historical graph of downloads
References found in this work
Ethical Criteria for Human Trials of Stem-Cell-Derived Dopaminergic Neurons in Parkinson's Disease.Samia A. Hurst, Alex Mauron, Shahan Momjian & Pierre R. Burkhard - 2015 - American Journal of Bioethics Neuroscience 6 (1):52-60.
Evaluating the First-in-Human Clinical Trial of a Human Embryonic Stem Cell-Based Therapy.Audrey R. Chapman & Courtney C. Scala - 2012 - Kennedy Institute of Ethics Journal 22 (3):243-261.
